AstraZeneca acknowledges covid vaccine can lead to rare side effect TSS in court; Here's what we know
AstraZeneca has acknowledged that its Covid-19 vaccine can lead to a rare side effect known as Thrombosis with Thrombocytopenia Syndrome (TTS). This admission comes as the company faces a lawsuit alleging severe harm and deaths caused by the vaccine, according to The Telegraph.
TTS is thrombosis with thrombocytopenia syndrome, which is basically a clot in blood vessels of the brain or elsewhere, along with a low platelet count. It is known to occur in very rare instances following certain types of vaccines and also from other causes. According to the WHO, adenovirus vector vaccines in particular have been rarely associated with this condition. Although COVID vaccines have prevented numerous deaths, reports of these extremely rare but potentially serious immune-mediated events have also been published in reputed journals, said Dr Rajeev Jayadevan, Co-Chairman National IMA COVID Task Force, Kerala.
AstraZeneca, which collaborated with the University of Oxford to develop the vaccine, is currently embroiled in legal proceedings initiated by victims and their families. One such case involves Jamie Scott, a father of two, who took legal action after suffering a blood clot that left him unable to work. Scott claims that following his vaccination in April 2021, he developed a «blood clot and a bleed on his brain,» resulting in a lasting brain injury.
Kate, Scott's wife, stated, «The medical world has acknowledged for a long time that vaccine-induced immune thrombocytopenia and thrombosis (VITT) was caused by the vaccine.»
